HLTH

HLTH
Name	HLTH
Status	Active
Genre	Healthcare innovation conference
Frequency	Annual
Country	United States
First	2016
Organizer	Oliver Wyman (original), Informa (current)

HLTH HLTH is an annual healthcare industry conference that convenes executives, entrepreneurs, investors, policymakers, and providers to discuss innovation, policy, technology, and financing in healthcare. The event draws participants from major corporations, startup ecosystems, academic centers, and government agencies, bringing together panels, keynotes, exhibitions, and networking sessions. HLTH functions as a marketplace for partnerships among pharmaceutical companies, health systems, payers, venture capital firms, and technology vendors.

Overview

HLTH positions itself as a nexus for stakeholders from Pfizer, Johnson & Johnson, UnitedHealth Group, CVS Health, Cleveland Clinic, Mayo Clinic, Kaiser Permanente, Mount Sinai Health System, Massachusetts General Hospital, and Cedars-Sinai Medical Center to engage with investors from Sequoia Capital, Andreessen Horowitz, Kleiner Perkins, NEA (New Enterprise Associates), and General Catalyst. The conference typically hosts startup showcases featuring companies linked to incubators like Y Combinator, Techstars, Startup Health, and accelerators tied to Plug and Play Tech Center. Attendees include executives with ties to regulatory and policy institutions such as the U.S. Food and Drug Administration, Centers for Medicare & Medicaid Services, National Institutes of Health, and lawmakers from the United States Congress.

History and Development

HLTH emerged in the mid-2010s amid a wave of healthcare technology conferences alongside events like JPMorgan Healthcare Conference, Health 2.0, HIMSS Global Health Conference & Exhibition, and TEDMED. Founders and early organizers leveraged networks spanning consulting firms like Oliver Wyman and media companies such as Informa and Reed Exhibitions. Over successive editions, HLTH expanded programming to mirror agendas seen at World Economic Forum sessions and summit formats similar to SXSW, recruiting speakers from institutions like Harvard Medical School, Stanford Medicine, Johns Hopkins Medicine, Columbia University Irving Medical Center, and University of California, San Francisco.

Annual Conferences and Events

Each HLTH edition is structured around plenary keynotes, thematic tracks, startup pitch competitions, and an exhibition floor hosting vendors including Philips, Siemens Healthineers, GE Healthcare, IBM Watson Health, and Roche. Satellite events and affiliated meetings attract participants from venture firms such as Bessemer Venture Partners and corporate venture arms like GV (company), Novartis Venture Fund, and Pfizer Ventures. The conference has been held in major venues in cities that host comparable gatherings like Las Vegas Convention Center, Boston Convention and Exhibition Center, and venues in New York City and San Diego. Special sessions have featured collaborations with organizations like World Health Organization, Bill & Melinda Gates Foundation, Rockefeller Foundation, and industry groups such as American Medical Association and HL7 International.

Key Themes and Topics

Common HLTH themes mirror priorities of entities such as Moderna, Regeneron Pharmaceuticals, Gilead Sciences, AbbVie, and Bristol Myers Squibb, including digital health platforms, telemedicine, value-based care models promoted by Blue Cross Blue Shield Association, precision medicine initiatives tied to Broad Institute, artificial intelligence applications from labs like DeepMind and OpenAI, interoperability efforts aligned with SMART on FHIR proponents, supply chain resilience discussed by players like McKesson and Cardinal Health, and clinical trial innovation involving Pfizer and Novartis. Panels examine reimbursement and payment reform issues relevant to Medicare and Medicaid policy, data privacy debates engaging stakeholders such as Apple Inc., Google (company), Microsoft, and cybersecurity firms with ties to Deloitte and PwC.

Notable Speakers and Participants

HLTH stages speakers drawn from corporate, academic, startup, and policy arenas including CEOs and executives formerly or currently at Aetna, Anthem, Inc., Eli Lilly and Company, Oracle Corporation, and Amazon (company) healthcare initiatives. High-profile participants have included leaders associated with Barack Obama-era health policy, senior officials from the Department of Health and Human Services, and researchers affiliated with National Cancer Institute, Stanford University School of Medicine, Yale School of Medicine, and University of Pennsylvania Perelman School of Medicine. Venture investors, entrepreneurs from Flatiron Health, Zocdoc, Oscar Health, and founders from promising startups have served on panels alongside executives from Goldman Sachs and Morgan Stanley investment teams.

Industry Impact and Criticism

Proponents cite HLTH for facilitating partnerships among stakeholders such as Boston Scientific, Stryker Corporation, Intuitive Surgical, and insurer-provider collaboratives tied to Cleveland Clinic and Mayo Clinic that accelerate product commercialization and adoption. Critics — including commentators from outlets like The New York Times, The Wall Street Journal, and Bloomberg L.P. — argue that large conferences can privilege incumbents, create networking echo chambers frequented by firms like McKinsey & Company and Boston Consulting Group, and underrepresent frontline clinicians from community systems such as Community Health Systems. Concerns are also raised about commercial influence by pharmaceutical and medical device firms, the environmental footprint of large gatherings in cities like Las Vegas and Boston, and access barriers for international participants from regions represented by World Bank and International Monetary Fund programs.

Category:Healthcare conferences